產(chǎn)品中心Cell Resources
聯(lián)系我們CONTACT US
400-999-210024小時(shí)服務(wù)熱線
產(chǎn)品概述
| 名稱 | U251 (人膠質(zhì)瘤細(xì)胞) (STR鑒定正確) |
| 別稱 | U-251 MG; U-251-MG; U-251_MG; U251-MG; U251MG; U-251; U251; U251n; U251N; 251 MG; 251MG |
| 種屬 | 人 |
| 生長特性 | 貼壁細(xì)胞 |
| 細(xì)胞形態(tài) | 成纖維細(xì)胞樣 |
| 凍存條件 | 凍存液：55% 基礎(chǔ)培養(yǎng)基+40%FBS+5%DMSO 溫度：液氮 |
| 培養(yǎng)方案A（默認(rèn)） |
培養(yǎng)條件:
氣相：空氣，95%；CO2，5%, 溫度：37℃
|
| 推薦傳代比例 | 1:2-1:4 |
| 推薦換液頻率 | 2-3次/周 |
| 背景描述 | U251細(xì)胞源自一位患者的膠質(zhì)母細(xì)胞瘤組織。 |
| 年齡（性別） | 男性；75歲 |
| 組織來源 | 腦組織 |
| 細(xì)胞類型 | 腫瘤細(xì)胞 |
| 腫瘤類型 | 膠質(zhì)瘤細(xì)胞 |
| 倍增時(shí)間 | ~24 hours |
| 保藏機(jī)構(gòu) | ECACC; 09063001 |
STR鑒定
-
STR位點(diǎn)信息
Amelogenin X CSF1PO 11,12 D2S1338 22,24 D3S1358 16,17 D5S818 11,12 D7S820 10,12 D8S1179 13,15 D13S317 10,11 D16S539 12 D18S51 13 D19S433 13,15 D21S11 29 FGA 21,25 PentaD 12 PentaE 7,10 TH01 9.3 TPOX 8 vWA 16,18 D6S1043 12 D12S391 17,22 D2S441 11 -
STR鑒定圖
-
參考文獻(xiàn)
-
Sphingosine kinase 1 promotes growth of glioblastoma by increasing inflammation mediated by the NF-κB /IL-6/STAT3 and JNK/PTX3 pathways(2022/09/29)
作者：Wan Li, Hongqing Cai, Liwen Ren
期刊：Acta Pharmaceutica Sinica B
DOI：10.1016/j.apsb.2022.09.012
影響因子 ：14.500
-
Chitinase-3 like-protein-1 promotes glioma progression via the NF-κB signaling pathway and tumor microenvironment reprogramming.(2022/10/03)
作者：Ting Zhao, Jianming Zeng, Yujie Xu
期刊：Theranostics
影響因子 ：12.400
-
Epigenetically regulated lncRNAs dissect the intratumoural heterogeneity and facilitate immune evasion of glioblastomas(2023/03/05)
作者：Dahua Xu, Meng Cao, Bo Wang, Xiaoman Bi
期刊：Theranostics
影響因子 ：12.400
-
Hypoxia induced ferritin light chain (FTL) promoted epithelia mesenchymal transition and chemoresistance of glioma(2020/07/16)
作者：Junhui Liu, Lun Gao, Na Zhan
期刊：Journal Of Experimental & Clinical Cancer Research
DOI：10.1186/s13046-020-01641-8
影響因子 ：11.300
-
Warburg effect-promoted exosomal circ_0072083 releasing up-regulates NANGO expression through multiple pathways and enhances temozolomide resistance in glioma(2021/05/11)
作者：Chenyu Ding, Xuehan Yi, Xiangrong Chen
期刊：Journal Of Experimental & Clinical Cancer Research
DOI：10.1186/s13046-021-01942-6
影響因子 ：11.300
-
circMMD reduction following tumor treating fields inhibits glioblastoma progression through FUBP1/FIR/DVL1 and miR-15b-5p/FZD6 signaling(2023/03/17)
作者：Shengchao Xu, Chengke Luo, Dikang Chen
期刊：JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
DOI：10.1186/s13046-023-02642-z
影響因子 ：11.300
引用產(chǎn)品：CL-0237
-
Histone demethylase JMJD1C promotes the polarization of M1 macrophages to prevent glioma by upregulating miR-302a(2021/09/26)
作者：Chuanhong Zhong, Bei Tao, Feilong Yang
期刊：Clinical and Translational Medicine
DOI：10.1002/ctm2.424
影響因子 ：10.600
引用產(chǎn)品：CL-0237
-
A novel mitochondria-targeting DHODH inhibitor induces robust ferroptosis and alleviates immune suppression(2024/02/27)
作者：Yongrui Hai, Renming Fan, Ting Zhao
期刊：PHARMACOLOGICAL RESEARCH
DOI：10.1016/j.phrs.2024.107115
影響因子 ：9.300
引用產(chǎn)品：CL-0237
-
CircIQGAP1 regulates RCAN1 and RCAN2 through the mechanism of ceRNA and promotes the growth of malignant glioma(2023/10/31)
作者：Xiang Huang, Ziheng Wang, Mengruo Song
期刊：PHARMACOLOGICAL RESEARCH
DOI：10.1016/j.phrs.2023.106979
影響因子 ：9.300
引用產(chǎn)品：CL-0237
-
Genome-wide CRISPR/Cas9 screening identifies CARHSP1 responsible for radiation resistance in glioblastoma(2021/07/21)
作者：Guodong Zhu, Jing Yu, Zhengyu Sun
期刊：Cell Death & Disease
DOI：10.1038/s41419-021-04000-3
影響因子 ：9.000
-
In situ visualization of the cellular uptake and sub-cellular distribution of mussel oligosaccharides(2024/01/04)
作者：Zhenjie Yu, Huarong Shao, Xintian Shao
期刊：Journal of Pharmaceutical Analysis
DOI：10.1016/j.jpha.2023.12.022
影響因子 ：8.800
引用產(chǎn)品：CL-0237
-
A novel inflammation-related lncRNAs prognostic signature identifies LINC00346 in promoting proliferation, migration, and immune infiltration of glioma(2022/10/13)
作者：Wenjing Zeng, Lei Zhang, Hui Cao
期刊：Frontiers in Immunology
影響因子 ：8.786
引用產(chǎn)品：CL-0237
-
Acidic Environment-Responsive Metal Organic Framework-Mediated Dihydroartemisinin Delivery for Triggering Production of Reactive Oxygen Species in Drug-Resistant Lung Cancer(2024/04/29)
作者：Xiaojie Yan, Xueying Zhao, Mingde Fan
期刊：International Journal of Nanomedicine
影響因子 ：8.000
引用產(chǎn)品：CL-0237
-
MicroRNA-22 represses glioma development via activation of macrophage-mediated innate and adaptive immune responses(2022/03/12)
作者： JiajieTu, Yilong Fang, Dafei Han
期刊：Oncogene
DOI：10.1038/s41388-022-02236-7
影響因子 ：8.000
-
The development of an anti-cancer peptide M1-21 targeting transcription factor FOXM1(2023/06/21)
作者：Haojie Cheng, Jie Yuan, Chaozhu Pei
期刊：Cell and Bioscience
DOI：10.1186/s13578-023-01059-7
影響因子 ：7.500
-
Multi-omics analysis reveals the involvement of origin recognition complex subunit 6 in tumor immune regulation and malignant progression(2023/10/12)
作者：Jinfeng Zhu, Qitong Chen, Liyun Zeng
期刊：Frontiers in Immunology
DOI：10.3389/fimmu.2023.1236806
影響因子 ：7.300
引用產(chǎn)品：CL-0237
-
A novel prognostic related lncRNA signature associated with amino acid metabolism in glioma(2023/04/11)
作者：Qiang Lei, Bo Yuan, Kun Liu
期刊：Frontiers in Immunology
DOI：10.3389/fimmu.2023.1014378
影響因子 ：7.300
-
Hsa_circ_0021205 enhances lipolysis via regulating miR-195-5p/HSL axis and drives malignant progression of glioblastoma(2024/02/10)
作者：Suwen Li, Jiaqi Yuan, Zhe Cheng
期刊：Cell Death Discovery
DOI：10.1038/s41420-024-01841-7
影響因子 ：7.000
引用產(chǎn)品：CL-0237
-
Neogenin suppresses tumor progression and metastasis via inhibiting Merlin/YAP signaling(2023/02/06)
作者：Xiaohan Hu, Li Li, Fang Li
期刊：Cell Death Discovery
DOI：10.1038/s41420-023-01345-w
影響因子 ：7.000
-
E2F2 drives glioma progression via PI3K/AKT in a PFKFB4-dependent manner(2021/03/24)
作者：Longzhou Zhang,?Zengjin Liu,?Yang Dong
期刊：Life Sciences
影響因子 ：6.780
-
N-2-(phenylamino) benzamide derivatives as novel anti-glioblastoma agents: Synthesis and biological evaluation(2021/09/10)
作者：Junfang Li, Xiaoling Hu, Tian Luo
期刊：European Journal Of Medicinal Chemistry
DOI：10.1016/j.ejmech.2021.113817
影響因子 ：6.700
-
Design, synthesis, and biological evaluation of novel spirocyclic compounds as potential anti-glioblastoma agents(2023/06/25)
作者：Heping Zhu, Xiaomin Song, Yihui Pan
期刊：EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
DOI：10.1016/j.ejmech.2023.115595
影響因子 ：6.700
-
IDH1 mutation produces R-2-hydroxyglutarate (R-2HG) and induces mir-182-5p expression to regulate cell cycle and tumor formation in glioma(2024/05/17)
作者：Haiting Zhao, Li Meng, Peng Du
期刊：BIOLOGICAL RESEARCH
DOI：10.1186/s40659-024-00512-2
影響因子 ：6.700
引用產(chǎn)品：CL-0237
-
N6‐methyladenosine‐modified HOTAIRM1 promotes vasculogenic mimicry formation in glioma(2022/10/27)
作者：Zhangyi Wu, Yihai Lin, Nan Wei
期刊：CANCER SCIENCE
影響因子 ：6.518
引用產(chǎn)品：CL-0237
-
Carbon Ion Irradiation Downregulates Notch Signaling in Glioma Cell Lines, Impacting Cell Migration and Spheroid Formation(2022/10/24)
作者：Vivek Kumar, Mohit Vashishta, Lin Kong
期刊：Cells
影響因子 ：6.000
-
Immune cell infiltration and drug response in glioblastoma multiforme: insights from oxidative stress-related genes(2024/04/02)
作者：Kan Wang, Yifei Xiao, Ruipeng Zheng
期刊：Cancer Cell International
DOI：10.1186/s12935-024-03316-2
影響因子 ：5.800
引用產(chǎn)品：CL-0237
-
Overexpression of GINS4 is associated with poor prognosis and survival in glioma patients(2021/09/23)
作者：Binfeng Liu, Zhendong Liu, Yanbiao Wang
期刊：Molecular Medicine
DOI：10.1186/s10020-021-00378-0
影響因子 ：5.700
-
Overexpressed XRCC2 as an independent risk factor for poor prognosis in glioma patients(2021/05/29)
作者：Zhendong Liu, Wang Zhang, Xingbo Cheng
期刊：Molecular Medicine
DOI：10.1186/s10020-021-00316-0
影響因子 ：5.700
-
Nifuroxazide inhibits the growth of glioblastoma and promotes the infiltration of CD8 T cells to enhance antitumour immunity(2023/03/14)
作者：Xinzhuang Wang, Junyi Ye, Ming Gao
期刊：INTERNATIONAL IMMUNOPHARMACOLOGY
DOI：10.1016/j.intimp.2023.109987
影響因子 ：5.600
-
A TGF-β signaling-related lncRNA signature for prediction of glioma prognosis, immune microenvironment, and immunotherapy response(2023/10/18)
作者：Wei-Wei Duan, Li-Ting Yang, Jian Liu
期刊：CNS Neuroscience & Therapeutics
影響因子 ：5.500
引用產(chǎn)品：CL-0237
-
Prognosis and therapeutic significance of IGF-1R-related signaling pathway gene signature in glioma(2024/04/11)
作者：Zhen Liu, Liangwang Yang, Wenqi Wu
期刊：Frontiers in Cell and Developmental Biology
DOI：10.3389/fcell.2024.1375030
影響因子 ：5.500
引用產(chǎn)品：CL-0237
-
RNA-binding protein DHX9 promotes glioma growth and tumor-associated macrophages infiltration via TCF12(2022/11/15)
作者：Liang Liu, Xuelan Zhou, Shan Cheng, Yuyuan Ge, Baomin Chen, Jia Shi, Haoran Li, Suwen Li, Yongdong Li, Jiaqi Yuan, Anyi Wu, Xinglei Liu, Shilu Huang, Zhipeng Xu, Jun Dong
期刊：CNS Neuroscience & Therapeutics
影響因子 ：5.500
引用產(chǎn)品：CL-0012 CL-0233 CL-0237 CL-0458 CL-0578 CL-0583 CP-H122
-
A novel immunogenic cell death-related gene risk signature can identify biomarkers of gliomas and predict the immunotherapeutic response(2024/01/15)
作者：Xuewu Tang, Kan Wang, Jinchao Yang
期刊：American Journal of Cancer Research
DOI：PMID:38323285
影響因子 ：5.300
引用產(chǎn)品：CL-0237
-
ITGB3BP is a potential biomarker associated with poor prognosis of glioma( 2021/12/24)
作者：Zhendong Liu, Binfeng Liu, Lu Bian
期刊：Journal of Cellular and Molecular Medicine
影響因子 ：5.300
-
lncRNA TUSC7 sponges miR-10a-5p and inhibits BDNF/ERK pathway to suppress glioma cell proliferation and migration(2023/04/14)
作者：Runhui Wang, Jia Wang, Yuanyu Wang
期刊：Aging-US
影響因子 ：5.200
-
BCL2A1 is associated with tumor-associated macrophages and unfavorable prognosis in human gliomas.(2023/10/25)
作者：Lun Gao, Zhang Ye, Shu Peng
期刊：Aging-US
影響因子 ：5.200
引用產(chǎn)品：CL-0237
-
A systematic framework for identifying prognostic necroptosis-related lncRNAs and verification of lncRNA CRNDE/miR-23b-3p/IDH1 regulatory axis in glioma(2023/11/06)
作者：Yangxia Chen, Di Hu, Fang Wang
期刊：Aging-US
影響因子 ：5.200
引用產(chǎn)品：CL-0237
-
The Liquid-Fermentation Formulation of Sanghuangporus sanghuang Optimized by Response Surface Methodology and Evaluation of Biological Activity of Extracellular Polysaccharides(2024/04/13)
作者：Yuhan Gao, Xiaomin Li, Hui Xu
期刊：Foods
影響因子 ：5.200
引用產(chǎn)品：CL-0237
-
Knockdown of PGBD5 inhibits the malignant progression of glioma through upregulation of the PPAR pathway(2024/04/05)
作者：Pengren Luo, Jinhong Yang, Lipeng Jian
期刊：INTERNATIONAL JOURNAL OF ONCOLOGY
影響因子 ：5.200
引用產(chǎn)品：CL-0237
-
LINC01087 inhibits glioma cell proliferation and migration, and increases cell apoptosis via miR-384/Bcl-2 axis(2021/08/30)
作者：Yaohui Tian, Linwei Jia, Zhifeng Liu
期刊：Aging-US
影響因子 ：5.200
引用產(chǎn)品：CL-0237
-
DNA Damage-Induced Apoptosis Suppressor Triggers Progression and Stemness of Glioma by Enhancing Lymphoid Enhancer-Binding Factor 1 Expression(2024/03/21)
作者：Youlin Chen, Yi Liu, Yan Xu
期刊：World Journal of Oncology
影響因子 ：5.200
引用產(chǎn)品：CL-0237
-
FDX1 serves as a prognostic biomarker and promotes glioma progression by regulating the immune response(2023/06/10)
作者：Guangying Zhang, Liangfang Shen, Zhanzhan Li
期刊：Aging-US
影響因子 ：5.200
-
Isobavachalcone’s Alleviation of Pyroptosis Contributes to Enhanced Apoptosis in Glioblastoma: Possible Involvement of NLRP3(2022/09/02)
作者：Yueshan Wu, Jing Chang, Juanjuan Ge
期刊：MOLECULAR NEUROBIOLOGY
DOI：10.1007/s12035-022-03010-2
影響因子 ：5.100
-
Lemur tyrosine kinase 2 has a tumor-inhibition function in human glioblastoma by regulating the RUNX3/Notch pathway(2023/06/02)
作者：Lei Zhang, Peng Luo, Xinggang Mao
期刊：BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
DOI：10.1016/j.bbamcr.2023.119509
影響因子 ：5.100
引用產(chǎn)品：164210-50 CL-0012 CL-0237 CL-0238 CL-0458 CL-0583 PB180120 PM150210 PM150410
-
GD2 CAR-T cells in combination with Nivolumab exhibit enhanced antitumor efficacy(2023/03/24)
作者：Guangji Zhang, Yu Zhao, Zhongfeng Liu
期刊：Translational Oncology
DOI：10.1016/j.tranon.2023.101663
影響因子 ：5.000
-
Tenacissoside H repressed the progression of glioblastoma by inhibiting the PI3K/Akt/mTOR signaling pathway(2024/02/07)
作者：Jianhong Dong, Yiming Qian, Wei Zhang
期刊：EUROPEAN JOURNAL OF PHARMACOLOGY
DOI：10.1016/j.ejphar.2024.176401
影響因子 ：5.000
引用產(chǎn)品：CL-0237
-
Circular RNA 0010117 promotes aggressive glioblastoma behavior by regulating the miRNA-6779-5p/SPEN axis(2022/09/07)
作者：Xuanyong Yang, Yue Liu, Xinhui Zhou
期刊：Translational Oncology
DOI：10.1016/j.tranon.2022.101515
影響因子 ：5.000
-
ZIKV infection differentially affects the transcriptional profiles in HTR8 and U251 cells(2023/07/07)
作者：Qiqi Chen, Nina Li, Shike Zeng
期刊：VIRUS RESEARCH
DOI：10.1016/j.virusres.2023.199166
影響因子 ：5.000
引用產(chǎn)品：CL-0237
-
LINC01088 promotes the growth and invasion of glioma cells through regulating small nuclear ribonucleoprotein polypeptide A transcription(2022/04/07)
作者：Tao Peng, Dongliang Chen, Shilan Chen
期刊：Bioengineered.
DOI：10.1080/21655979.2022.2051786
影響因子 ：4.900
-
Integration analysis of single-cell and spatial transcriptomics reveal the cellular heterogeneity landscape in glioblastoma and establish a polygenic risk model(2023/06/15)
作者：Yaxuan Liu, Zhenyu Wu, Yueyuan Feng
期刊：Frontiers in Oncology
影響因子 ：4.700
-
CASP6 predicts poor prognosis in glioma and correlates with tumor immune microenvironment.(2022/09/02)
作者：Kai Guo, Jiahui Zhao, Qianxu Jin
期刊：Frontiers in Oncology
影響因子 ：4.700
-
EDEM2 is a diagnostic and prognostic biomarker and associated with immune infiltration in glioma: A comprehensive analysis(2023/01/16)
作者：Yuxi Wu, Haofei Wang, Wei Xiang
期刊：Frontiers in Oncology
影響因子 ：4.700
引用產(chǎn)品：CL-0237
-
The Circ_0001367/miR-545-3p/LUZP1 Axis Regulates Cell Proliferation, Migration and Invasion in Glioma Cells(2021/11/18)
作者：Dong Xuchen, Zhang Peng, Liu Liang
期刊：Frontiers in Oncology
影響因子 ：4.700
-
Long Non-Coding RNA H19 Regulates Glioma Cell Growth and Metastasis via miR-200a-Mediated CDK6 and ZEB1 Expression(2021/11/2)
作者：Xuezhu Chen, Yuhong Li, Chenghai Zuo
期刊：Frontiers in Oncology
影響因子 ：4.700
-
β3GNT9 as a prognostic biomarker in glioblastoma and its association with glioblastoma immune infiltration, migration and invasion(2023/09/12)
作者：YingHao Luo, Kan Wang, Lu Zhan
期刊：Frontiers in Oncology
影響因子 ：4.700
-
The overexpression and clinical significance of TBX15 in human gliomas(2023/06/16)
作者：Dongming Yan, Yaping Yu, Qiongwei Ni
期刊：Scientific Reports
DOI：10.1038/s41598-023-36410-y
影響因子 ：4.600
-
A Potential Anti-Glioblastoma Compound LH20 Induces Apoptosis and Arrest of Human Glioblastoma Cells via CDK4/6 Inhibition(2023/06/28)
作者：Yan Wang, Youbin Li, Dong Liu
期刊：MOLECULES
影響因子 ：4.600
-
LncRNA RARA-AS1 could serve as a novel prognostic biomarker in pan-cancer and promote proliferation and migration in glioblastoma(2023/10/13)
作者：Yue Huang, Song Deng, Qiaoji Jiang
期刊：Scientific Reports
DOI：10.1038/s41598-023-44677-4
影響因子 ：4.600
引用產(chǎn)品：CL-0237
-
Daphnetin Improves Neuropathic Pain by Inhibiting the Expression of Chemokines and Inflammatory Factors in the Spinal Cord and Interfering with Glial Cell Polarization(2023/02/06)
作者：Tianrui Zhang, Wulin Liang, Mingqian Zhang
期刊：Pharmaceuticals
影響因子 ：4.600
-
Study on the Inhibitory Effect of Curcumin on GBM and Its Potential Mechanism(2022/09/30)
作者：Xiaotao Su, Shaohua Chen, Hongyu Lu
期刊：Drug Design Development and Therapy
影響因子 ：4.319
引用產(chǎn)品：CL-0237
-
Glioma-Derived Exosome Lncrna Agap2-As1 Promotes Glioma Proliferation and Metastasis By Mediating Tgf-β1 Secretion of Myeloid-Derived Suppressor Cells(2024/04/18)
作者：Yanlong Tian, Xiao Gao, Xuechao Yang
期刊：Heliyon
DOI：10.1016/j.heliyon.2024.e29949
影響因子 ：4.000
引用產(chǎn)品：CL-0237
-
Zinc finger and SCAN domain-containing 18 suppresses the proliferation, self-renewal, and drug resistance of glioblastoma cells(2023/06/03)
作者：Yan Wang, Jingwei Peng, Chenchen Song
期刊：Heliyon
DOI：10.1016/j.heliyon.2023.e17000
影響因子 ：4.000
引用產(chǎn)品：CL-0237
-
Phospholipid scramblase 1 acts through the IL-6/JAK/STAT3 pathway to promote the malignant progression of glioma(2024/04/16)
作者：ShiZhen Zhou, Jun Xu, YuFang Zhu
期刊：ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
影響因子 ：3.900
引用產(chǎn)品：CL-0237
-
Zeaxanthin impairs angiogenesis and tumor growth of glioblastoma: An in vitro and in vivo study(2024/03/11)
作者：Feifei Lu, Qing Wu, Jiaming Lei
期刊：ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
影響因子 ：3.900
引用產(chǎn)品：CL-0237
-
MiR-760 exerts a critical regulatory role in glioma proliferation, migration, and invasion by modulating MMP2 expression.(2024/04/08)
作者：Zhengting Qian, Heng Xin, Zhen Jia
期刊：Journal of Cancer
影響因子 ：3.900
引用產(chǎn)品：CL-0237
-
CircCDC45 promotes the malignant progression of glioblastoma by modulating the miR-485-5p/CSF-1 axis(2021/10/09)
作者：Rongcai Liu, Weimin Dai, An Wu
期刊：Bmc Cancer
DOI：10.1186/s12885-021-08803-7
影響因子 ：3.800
-
Glioma malignancy is linked to interdependent and inverse AMOG and L1 adhesion molecule expression(2019/9/12)
作者：Qiong Jiang,?Qing Xie,?Chengliang Hu
期刊：Bmc Cancer
影響因子 ：3.800
-
Abietane diterpenoids from Phlegmariurus carinatus and their biological activities(2022/09/28)
作者：Jiawei Hu, Qiang Wang, Lin Liu
期刊：PHYTOCHEMISTRY
DOI：10.1016/j.phytochem.2022.113457
影響因子 ：3.800
引用產(chǎn)品：CL-0237
-
Silencing lncRNA LINC01410 suppresses cell viability yet promotes apoptosis and sensitivity to temozolomide in glioblastoma cells by inactivating PTEN/AKT pathway via targeting miR-370-3p(2021/08/26)
作者：Tingkai Fu, Yunxue Yang, Zhenxin Mu
期刊：Immunopharmacology and Immunotoxicology
DOI：10.1080/08923973.2021.1966031
影響因子 ：3.712
引用產(chǎn)品：CL-0237
-
Circ_0001588 Upregulates ERBB4 to Promote Glioma Malignant Progression Through Sponging miR-1281(2022/01/04)
作者：Jun Wang,?Juan Li,?Peng Duan
期刊：Neurotoxicity Research
DOI：10.1007/s12640-021-00464-5
影響因子 ：3.700
-
CircRNA circ_POSTN promotes the malignancy of glioma by regulating the miR-433-3p/SPARC axis(2022/12/01)
作者：Xiangting Hua, Chaoyong Zhang, Yongfeng Ba
期刊：METABOLIC BRAIN DISEASE
DOI：10.1007/s11011-022-01126-x
影響因子 ：3.600
-
Etomidate inhibits tumor growth of glioblastoma by regulating M1 macrophage polarization(2024/02/01)
作者：Caiyan Gao, Yan Nie
期刊：METABOLIC BRAIN DISEASE
DOI：10.1007/s11011-023-01335-y
影響因子 ：3.600
引用產(chǎn)品：CL-0237
-
miRNA-660-3p inhibits malignancy in glioblastoma via negative regulation of APOC1-TGFβ2 signaling pathway(2023/11/19)
作者：Zelin Yang, Liang Yang, Zhenkai Sun
期刊：CANCER BIOLOGY & THERAPY
DOI：10.1080/15384047.2023.2281459
影響因子 ：3.600
引用產(chǎn)品：CL-0237
-
EIF4A3-induced circCCNB1 (hsa_circ_0001495) promotes glioma progression by elevating CCND1 through interacting miR-516b-5p and HuR(2022/01/17)
作者：Xiaoli Li, Chengmou Wang, Guanghui Chen
期刊： Metabolic Brain Disease
DOI：10.1007/s11011-021-00899-x
影響因子 ：3.600
引用產(chǎn)品：164210 CL-0012 CL-0237 CL-0238 CL-0583 PB180120 PM150210
-
Circular RNA circ_0000741/miR-379-5p/TRIM14 signaling axis promotes HDAC inhibitor (SAHA) tolerance in glioblastoma(2023/03/11)
作者：Liang Meng, Yuefei Wang, Qin Tu
期刊：METABOLIC BRAIN DISEASE
DOI：10.1007/s11011-023-01184-9
影響因子 ：3.600
-
Hsa_circ_0043949 reinforces temozolomide resistance via upregulating oncogene ITGA1 axis in glioblastoma(2022/10/27)
作者：Xuzhao Li, Nianhua Wang, Haibin Leng
期刊：METABOLIC BRAIN DISEASE
DOI：10.1007/s11011-022-01069-3
影響因子 ：3.600
-
Propofol inhibits glioma progression by regulating circMAPK4/miR-622/HOXA9 axis(2022/11/03)
作者：Xiao, Gaopeng, Yu, Liuqiong, Tan, Wenmin, Yang, Hao, Li, Wensen, Xia, Rongzhou, Li, Yujin
期刊：METABOLIC BRAIN DISEASE
DOI：10.1007/s11011-022-01099-x
影響因子 ：3.600
-
Circular RNA circ_0001588 sponges miR-211-5p to facilitate the progression of glioblastoma via up-regulating YY1 expression(2021/07/14)
作者：Qian Wang, Dahai Zheng, Yuhan Li
期刊：Journal Of Gene Medicine
DOI：10.1002/jgm.3371
影響因子 ：3.500
-
Deubiquitination of TNKS1 Regulates Wnt/β-Catenin to Affect the Expression of USP25 to Promote the Progression of Glioma(2022/04/11)
作者：Bin Tang, Hai Luo, Shenhao Xie
期刊：DISEASE MARKERS
影響因子 ：3.464
-
Inhibitory effect of gefitinib derivative LPY?9 on human glioma(2021/7/2)
作者：Yuchen Sun, Liangzhao Chu, Huijuan Wang
期刊：Molecular Medicine Reports
影響因子 ：3.400
引用產(chǎn)品：CL-0237
-
Novel tumor necrosis factor-related long non-coding RNAs signature for risk stratification and prognosis in glioblastoma(2023/04/20)
作者：Shengrong Long, Bingbing Wu, Liu Yang
期刊：Frontiers in Neurology
DOI：10.3389/fneur.2023.1054686
影響因子 ：3.400
-
FOXC1 silencing inhibits the epithelial?to?mesenchymal transition of glioma cells: Involvement of β?catenin signaling(2018/11/13)
作者：Qinchen Cao, Xinxin Wang, Yonggang Shi
期刊：Molecular Medicine Reports
影響因子 ：3.400
引用產(chǎn)品：CL-0237
-
Sevoflurane Represses Proliferation and Migration of Glioma Cells by Regulating the ANRIL/let-7b-5p Axis(2020/8/19)
作者：Yufeng Gao, Hui Ma, Dongnan Hou
期刊：Cancer Biother And Radiopharm
影響因子 ：3.400
引用產(chǎn)品：CL-0237
-
Exosome-transmitted ANGPTL1 suppresses angiogenesis in glioblastoma by inhibiting the VEGFA/VEGFR2/Akt/eNOS pathway(2023/12/15)
作者：Dong Wang, Huichen Li, Tianxiang Zeng
期刊：JOURNAL OF NEUROIMMUNOLOGY
DOI：10.1016/j.jneuroim.2023.578266
影響因子 ：3.300
引用產(chǎn)品：CL-0237
-
Enhanced Glycolysis Confers Resistance Against Photon but Not Carbon Ion Irradiation in Human Glioma Cell Lines(2023/01/03)
作者：Mohit Vashishta, Vivek Kumar, Chandan Guha
期刊：Cancer Management and Research
影響因子 ：3.300
引用產(chǎn)品：CL-0237
-
VSIG4 Silencing Inhibits Glioblastoma Growth by Regulating the JAK2/STAT3 Pathway(2023/06/02)
作者：Congying Zheng, Chengliang Mao, Kai Tang
期刊：Neuropsychiatric Disease and Treatment
影響因子 ：3.200
-
Optimization of Fermentation Culture Medium for Sanghuangporus alpinus Using Response-Surface Methodology(2024/05/06)
作者：Yuhan Gao, Xiaomin Li, Hui Xu
期刊：Horticulturae
DOI：10.3390/horticulturae10050474
影響因子 ：3.100
引用產(chǎn)品：CL-0237
-
CFTR activation suppresses glioblastoma cell proliferation, migration and invasion(2018/11/17)
作者：Xiao Zhong, Hongqi Chen, Xiuling Yang
期刊：Biochemical and Biophysical Research Communications
DOI：10.1016/j.bbrc.2018.12.080
影響因子 ：3.100
-
Bioinformatics Analysis and Experimental Validation for Exploring Key Molecular Markers for Glioblastoma(2024/03/06)
作者：Zhenchao Huang, Zhijie Chen, En’peng Song
期刊：APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
DOI：10.1007/s12010-024-04894-7
影響因子 ：3.000
引用產(chǎn)品：CL-0237
-
Neuregulin 1 enhances cell adhesion molecule L1 like expression levels and promotes malignancy in human glioma(2020/4/21)
作者：Wenwen Lin, Guanyong Ou, Jiazhe Lin
期刊：Oncology Letters
影響因子 ：2.900
-
HNF4G accelerates glioma progression by facilitating NRP1 transcription(2023/02/01)
作者：Hongmin Che, Qi Zheng, Zijun Liao
期刊：Oncology Letters
影響因子 ：2.900
-
Tumor-promoting function of PIMREG in glioma by activating the β-catenin pathway(2021/7/23)
作者：Dekang?Wang, Aili Hu, Hao Peng
期刊：3 BIOTECH
DOI：10.1007/s13205-021-02922-5
影響因子 ：2.800
-
Scinderin promotes glioma cell migration and invasion via remodeling actin cytoskeleton(2024/01/24)
作者：Xin Lin, Zhao Zhao, Shupeng Sun
期刊：World Journal of Clinical Oncology
影響因子 ：2.800
引用產(chǎn)品：CL-0237
-
PSMC2 promotes glioma progression by regulating immune microenvironment and PI3K/AKT/mTOR pathway(2024/03/30)
作者：Yizheng Wang, Shiyang Zhang, Zijun Zhao
期刊：IMMUNOBIOLOGY
DOI：10.1016/j.imbio.2024.152802
影響因子 ：2.800
引用產(chǎn)品：CL-0237
-
High LYRM4-AS1 predicts poor prognosis in patients with glioma and correlates with immune infiltration(2023/10/03)
作者：Haiyue Wang, Ying Xie, Hongzhen Du
期刊：PeerJ
影響因子 ：2.700
引用產(chǎn)品：CL-0237
-
Two Mixed-Ligand Co(II) Complexes as Luminescent Materials and Loaded with Temozolomide-gel Particles in Nursing Against Glioma(2024/04/16)
作者：Xuemei Li, Jinmin Qi, Zongxi Li
期刊：JOURNAL OF FLUORESCENCE
DOI：10.1007/s10895-024-03721-w
影響因子 ：2.700
引用產(chǎn)品：CL-0237
-
DNTTIP2 Expression is Associated with Macrophage Infiltration and Malignant Characteristics in Low-Grade Glioma(2022/11/19)
作者：Yuanjie Liu, Shuhong Zeng, Weihua Qian
期刊：Pharmacogenomics & Personalized Medicine
影響因子 ：2.606
引用產(chǎn)品：CL-0237
-
Raf/MEK/ERK Signaling Pathway Is Involved in the Inhibition of Glioma Cell Proliferation and Invasion in the Ketogenic Microe-nvironment(2023/07/27)
作者：Wentao Fan, Xiaofei Liu, Richu Liang
期刊：Current Medical Science
影響因子 ：2.400
引用產(chǎn)品：CL-0237
-
MicroRNA-640 Inhibition Enhances the Chemosensitivity of Human Glioblastoma Cells to Temozolomide by Targeting Bcl2 Modifying Factor(2022/08/19)
作者：Shu Jiang, Chao Luo, Yongli Chen
期刊：BIOCHEMICAL GENETICS
DOI：10.1007/s10528-022-10264-x
影響因子 ：2.400
引用產(chǎn)品：CL-0237
-
Hypoxic microenvironment-induced exosomes confer temozolomide resistance in glioma through transfer of pyruvate kinase M2(2024/04/10)
作者：Guofu Li, Ziyu Xiong, Ying Li
期刊：Discover Oncology
DOI：10.1007/s12672-024-00963-9
影響因子 ：2.200
引用產(chǎn)品：CL-0237
-
Low Expression of GRM4 Is Associated with Poor Prognosis and Tumor Immune Infiltration in Glioma(2023/12/19)
作者：Hai Fan, Dongming Yan, Xingyue Fang
期刊：INTERNATIONAL JOURNAL OF NEUROSCIENCE
DOI：10.1080/00207454.2023.2297646
影響因子 ：2.200
引用產(chǎn)品：CL-0237
-
Construction of a novel microRNA-based signature for predicting the prognosis of glioma(2022/03/30)
作者：Gaoxin Liu, Xiaoming Rong, Xinrou Lin
期刊：International Journal Of Neuroscience
DOI：10.1080/00207454.2021.1993848
影響因子 ：2.200
-
Silibinin suppresses glioblastoma cell growth, invasion, stemness, and glutamine metabolism by YY1/SLC1A5 pathway(2024/02/24)
作者：Ming Liu, Xipeng Liu, Jianxin Qiao
期刊：Translational Neuroscience
影響因子 ：2.100
引用產(chǎn)品：CL-0237
-
eEF1A1 regulates the expression and alternative splicing of genes associated with Parkinson’s disease in U251 cells(2024/05/22)
作者：Jing Lei, Guliqiemu Aimaier, Zaolaguli Aisha
期刊：Genes & Genomics
DOI：10.1007/s13258-024-01516-8
影響因子 ：2.100
引用產(chǎn)品：CL-0237
-
ADAMTS8 inhibits glioma development in vitro and in vivo(2023/07/14)
作者：Baosheng Zhou, Yong Liu, Guangshuo Ma
期刊：FOLIA NEUROPATHOLOGICA
影響因子 ：2.000
-
EEF1A1 is Involved the Regulating Neuroinflammatory Processes in Parkinsons Disease(2023/08/16)
作者：Zaolaguli Aisha, Jing Lei, Yan Zhang
期刊：Journal of Integrative Neuroscience
影響因子 ：1.800
-
Ursolic acid reverses hypoxia-driving radioresistance of glioma cells via SENP1/HIF‐1α axis(2024/05/21)
作者：Bailin Zhang, Han Peng, Jing Zhang
期刊：Molecular & Cellular Toxicology
DOI：10.1007/s13273-024-00452-8
影響因子 ：1.700
引用產(chǎn)品：CL-0237
-
circ_0082375 promotes the progression of glioma by regulating Wnt7B(2021/01/01)
作者：Xianbing Meng, Hailong Tian, Wenqiang Guo
期刊：Translational Neuroscience
影響因子 ：1.200
引用產(chǎn)品：CL-0237
-
Ginsenoside CK Induces the Mitochondrial Apoptosis in Glioma Cells Through the Activation of the p53-Bax-Caspase Pathway(2023/12/27)
作者：Yang Bai, Yuanhao Liu, Lihao Lin
期刊：Pharmacognosy Magazine
影響因子 ：0.700
引用產(chǎn)品：CL-0237
-
Lentinan Regulates Glioma Cell Proliferation and Apoptosis by Activating p53 and Caspases Pathways(2024/05/16)
作者：Ying Sun, Peng Gao, Xilin Wan
期刊：Pharmacognosy Magazine
影響因子 ：0.700
引用產(chǎn)品：CL-0237
FAQs
Q：{{item.question}}
A：
產(chǎn)品資料
識別碼示意圖
.png "梅文強(qiáng)")
